Literature DB >> 17255331

Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

Karim Hnia1, Gerald Hugon, François Rivier, Ahmed Masmoudi, Jacques Mercier, Dominique Mornet.   

Abstract

Duchenne muscular dystrophy muscles undergo increased oxidative stress and altered calcium homeostasis, which contribute to myofiber loss by trigging both necrosis and apoptosis. Here, we asked whether treatment with free radical scavengers could improve the dystrophic pattern of mdx muscles. Five-week-old mdx mice were treated for 2 weeks with alpha-lipoic acid/l-carnitine. This treatment decreased the plasmatic creatine kinase level, the antioxidant enzyme activity, and lipid peroxidation products in mdx diaphragm. Free radical scavengers also modulated the phosphorylation/activity of some component of the mitogen-activated protein kinase (MAPK) cascades: p38 MAPK, the extracellular signal-related kinase, and the Jun kinase. beta-Dystroglycan (beta-DG), a multifunctional adaptor or scaffold capable of interacting with components of the extracellular signal-related kinase-MAP kinase cascade, was also affected after treatment. In the mdx muscles, beta-DG (43 kd) was cleaved by matrix metalloproteinases into a 30-kd form (beta-DG30). We show that the proinflammatory protein nuclear factor-kappaB activator decreased after the treatment, leading to a significant reduction of matrix metalloproteinase activity in the mdx diaphragm. Our data highlight the implication of oxidative stress and cell signaling defects in dystrophin-deficient muscle via the MAP kinase cascade-beta-DG interaction and nuclear factor-kappaB-mediated inflammation process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255331      PMCID: PMC1851881          DOI: 10.2353/ajpath.2007.060344

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

Review 2.  The complexities of dystroglycan.

Authors:  S J Winder
Journal:  Trends Biochem Sci       Date:  2001-02       Impact factor: 13.807

3.  A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.

Authors:  John Muschler; Dinah Levy; Roseanne Boudreau; Michael Henry; Kevin Campbell; Mina J Bissell
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

4.  Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

Authors:  P D Côté; H Moukhles; M Lindenbaum; S Carbonetto
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  Effect of dl-alpha-lipoic acid on the status of lipid peroxidation and antioxidants in aged rats.

Authors:  P Arivazhagan; P Juliet; C Panneerselvam
Journal:  Pharmacol Res       Date:  2000-03       Impact factor: 7.658

6.  L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector.

Authors:  A Vanella; A Russo; R Acquaviva; A Campisi; C Di Giacomo; V Sorrenti; M L Barcellona
Journal:  Cell Biol Toxicol       Date:  2000       Impact factor: 6.691

7.  Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila.

Authors:  Wu-Min Deng; Martina Schneider; Richard Frock; Casimiro Castillejo-Lopez; Emily Anne Gaman; Stefan Baumgartner; Hannele Ruohola-Baker
Journal:  Development       Date:  2003-01       Impact factor: 6.868

8.  Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

Authors:  Ashok Kumar; Aladin M Boriek
Journal:  FASEB J       Date:  2003-03       Impact factor: 5.191

9.  Adherence influences monocyte responsiveness to interleukin-10.

Authors:  Anne-France Petit-Bertron; Catherine Fitting; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  J Leukoc Biol       Date:  2003-01       Impact factor: 4.962

10.  Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.

Authors:  M James; A Nuttall; J L Ilsley; K Ottersbach; J M Tinsley; M Sudol; S J Winder
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  31 in total

1.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  The effect of specific IKKβ inhibitors on the cytosolic expression of IκB-α and the nuclear expression of p65 in dystrophic (MDX) muscle.

Authors:  C George Carlson; Elizabeth Dole; Casey Stefanski; David Bayless
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

3.  Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.

Authors:  Daniel P Reay; Michele Yang; Jon F Watchko; Molly Daood; Terrence L O'Day; Khaleel K Rehman; Denis C Guttridge; Paul D Robbins; Paula R Clemens
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

4.  Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice.

Authors:  Satoru Hasegawa; Mikako Ito; Mayu Fukami; Miki Hashimoto; Masaaki Hirayama; Kinji Ohno
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

5.  Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.

Authors:  C A Morris; J T Selsby; L D Morris; K Pendrak; H L Sweeney
Journal:  J Appl Physiol (1985)       Date:  2010-09-16

6.  Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.

Authors:  Marni D Boppart; Dean J Burkin; Stephen J Kaufman
Journal:  Biochim Biophys Acta       Date:  2011-01-07

7.  L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.

Authors:  Karim Hnia; Jérôme Gayraud; Gérald Hugon; Michèle Ramonatxo; Sabine De La Porte; Stefan Matecki; Dominique Mornet
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

8.  Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors.

Authors:  Yuko Iwata; Yuki Katanosaka; Takashi Hisamitsu; Shigeo Wakabayashi
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

Authors:  Hong Li; Ashwani Mittal; Denys Y Makonchuk; Shephali Bhatnagar; Ashok Kumar
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

Review 10.  Therapeutic targeting of signaling pathways in muscular dystrophy.

Authors:  Shephali Bhatnagar; Ashok Kumar
Journal:  J Mol Med (Berl)       Date:  2009-10-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.